v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Series A Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2024 $ 5 $ 0 $ 0 $ 105,326 $ (105,081) $ 250
Balance (in Shares) at Dec. 31, 2024 47,101,631 8,207 0      
Share-based compensation expense $ 0 $ 0 $ 0 1,665 0 1,665
Dividends on convertible preferred stock $ 0 $ 0 $ 0 164 (164) 0
Dividends on convertible preferred stock (in Shares) 113,205 0 0      
Common Stock issued upon vesting of restricted stock units $ 0 $ 0 $ 0 0 0 0
Common Stock issued upon vesting of restricted stock units (in Shares) 63,199 0 0      
Common Stock and pre-funded warrants issued with Private Placement $ 0 $ 0 $ 0 543 0 543
Common Stock and pre-funded warrants issued with Private Placement (in Shares) 3,216,666 0 0      
Net (loss) income for the period $ 0 $ 0 $ 0 0 109 109
Balance at Mar. 31, 2025 $ 5 $ 0 $ 0 107,698 (105,136) 2,567
Balance (in Shares) at Mar. 31, 2025 50,494,701 8,207 0      
Balance at Dec. 31, 2025 $ 5 $ 0 $ 0 127,804 (116,319) 11,490
Balance (in Shares) at Dec. 31, 2025 51,733,217 8,207 4,500      
Share-based compensation expense $ 0 $ 0 $ 0 2,384 0 2,384
Dividends on convertible preferred stock $ 0 $ 0 $ 0 249 (249) 0
Dividends on convertible preferred stock (in Shares) 462,656 0 0      
Common Stock issued upon vesting of restricted stock units $ 0 $ 0 $ 0 0 0 0
Common Stock issued upon vesting of restricted stock units (in Shares) 72,888 0 0      
Common shares issued upon convertible preferred stock exercising convertible rights $ 0 $ 0 $ 0 0 0 0
Common shares issued upon convertible preferred stock exercising convertible rights (in Shares) 668,965 (100) (900)      
Common Stock and pre-funded warrants issued with Private Placement $ 0 $ 0 $ 0 5,000 0 5,000
Common Stock and pre-funded warrants issued with Private Placement (in Shares) 2,500,000 0 0      
Common shares issued upon warrant exercise $ 0 $ 0 $ 0 100 0 100
Common shares issued upon warrant exercise (in Shares) 68,966 0 0      
Net (loss) income for the period $ 0 $ 0 $ 0 0 (4,540) (4,540)
Balance at Mar. 31, 2026 $ 5 $ 0 $ 0 $ 135,537 $ (121,108) $ 14,434
Balance (in Shares) at Mar. 31, 2026 55,506,692 8,107 3,600